Respiratory
106 FDA-approved drugs
Recent Approvals
BECLOMETHASONE DIPROPIONATE
BECLOMETHASONE DIPROPIONATE
the relief of acute bronchospasm...
2025-12-16
AMNEAL IRELAND LTD
JASCAYD
NERANDOMILAST
idiopathic pulmonary fibrosis (IPF) in adult patients...
2025-10-07
Boehringer Ingelheim
BRINSUPRI
BRENSOCATIB
non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients 12 years of age and older...
2025-08-12
INSMED INC
ENFLONSIA
CLESROVIMAB-CFOR
the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and ...
2025-06-09
Merck
OMLYCLO
OMALIZUMAB-IGEC
acute bronchospasm or status asthmaticus...
2025-03-07
CELLTRION INC
IL-4IL-5IL-13
ALYFTREK
DEUTIVACAFTOR
cystic fibrosis (CF) in patients 6 years of age and older who have at least one F508del mutation or ...
2024-12-20
Vertex Pharmaceuticals
OHTUVAYRE
ENSIFENTRINE
the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients...
2024-06-26
VERONA PHARMA
TECHNEGAS KIT
TECHNETIUM TC-99M LABELED CARBON
TECHNEGAS, when used with sodium pertechnetate Tc 99m in the Technegas Plus System, provides technet...
2023-09-29
CYCLOMEDICA
OJJAARA
MOMELOTINIB DIHYDROCHLORIDE
intermediate or high-risk myelofibrosis (MF), including primary MF or secondary MF [post-polycythemi...
2023-09-15
GSK
JAK1JAK2JAK3
BEYFORTUS
NIRSEVIMAB-ALIP
the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in: Neonates and...
2023-07-17
AstraZeneca
TIOTROPIUM BROMIDE
TIOTROPIUM BROMIDE
the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive...
2023-06-20
Lupin
SYMBICORT AEROSPHERE
BUDESONIDE
Use s Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal...
2023-04-28
AstraZeneca
AIRSUPRA
ALBUTEROL SULFATE
the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations...
2023-01-10
AstraZeneca
XENOVIEW
XENON XE-129 HYPERPOLARIZED
use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric...
2022-12-23
POLAREAN
BREYNA
BUDESONIDE
asthma in patients 6 years of age and older...
2022-03-15
Viatris
VONJO
PACRITINIB CITRATE
adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential...
2022-02-28
SOBI
JAK1JAK2JAK3
TEZSPIRE
TEZEPELUMAB-EKKO
the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe...
2021-12-17
AstraZeneca
IL-5IL-13
ARFORMOTEROL TARTRATE
ARFORMOTEROL TARTRATE
the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in pat...
2021-06-22
Cipla
FORMOTEROL FUMARATE
FORMOTEROL FUMARATE
the long-term, twice daily (morning and evening) administration in the maintenance treatment of bron...
2021-06-22
Teva
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
FLUTICASONE PROPIONATE
Uses Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal co...
2020-12-17
Teva
Showing 20 of 106 drugs
Top Companies
Drug Classes
Corticosteroid 10
General Anesthetic 5
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator 4
Surfactant 3
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody 2
Anti-IgE 2
Kinase Inhibitor 2
Phosphodiesterase 4 Inhibitor 2
Leukotriene Receptor Antagonist 2
Phosphodiesterase 3 Inhibitor 1
Quick Stats
- Total Drugs
- 106
- Companies
- 57
- Drug Classes
- 20
- Latest Approval
- 2025-12-16